Processa Pharmaceuticals
PCSA
PCSA
19 hedge funds and large institutions have $691K invested in Processa Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$141K | |
| 2 | +$14K | |
| 3 | +$7.19K | |
| 4 |
VF
Virtu Financial
New York
|
+$6.7K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$30 |
Top Sellers
| 1 | -$183K | |
| 2 | -$25.8K | |
| 3 | -$24.5K | |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$23K |
| 5 |
BlackRock
New York
|
-$14.2K |